Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 17 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
P 2 (2)

Trial Status

Recruiting8
Unknown5
Not Yet Recruiting2
Withdrawn1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06929845Not ApplicableRecruiting

Organoid Models of Hepatocellular Carcinoma

NCT06907342Phase 2Recruiting

Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)

NCT06968598Not ApplicableNot Yet Recruiting

Analysis of Early Neurodevelopmental Alterations in Bipolar Disorder Based on Cortical Organoid Models

NCT06155305RecruitingPrimary

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer

NCT06658080Recruiting

Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer

NCT05323357RecruitingPrimary

Bern Human Organoid-Study to Study Host-microbe Interaction

NCT06315868Recruiting

Breast Cancer Subtype Characterization Through Patient's Derived Organoids.

NCT06100003Recruiting

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

NCT06100016Recruiting

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

NCT05378048Phase 2WithdrawnPrimary

Patient-derived-organoid (PDO) Guided Versus Conventional Therapy for Advanced Inoperable Abdominal Tumors

NCT02888587CompletedPrimary

The Innervation of Human Gut Sensory Epithelial Cells

NCT05644743Not Yet RecruitingPrimary

Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma

NCT04996355Unknown

Organoids-on-a-chip for Colorectal Cancer and in Vitro Screening of Chemotherapeutic Drugs

NCT04906733Unknown

Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.

NCT04555473UnknownPrimary

Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

NCT04279509Not ApplicableUnknownPrimary

Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)

NCT03577808UnknownPrimary

Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer

Showing all 17 trials

Research Network

Activity Timeline